Baring Asset Management’s Zimmer Biomet ZBH Stock Holding History

Baring Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-49,467	Closed	-$5.25M	–	166
2015 Q2	$5.25M	Sell	49,467 -50,199	-50%	-$5.55M	0.43%	66
2015 Q1	$11.4M	Sell	99,666 -30,752	-24%	-$3.51M	0.9%	39
2014 Q4	$14.4M	Sell	130,418 -11,194	-8%	-$1.18M	0.91%	35
2014 Q3	$13.8M	Buy	+141,612	New	+$13.9M	0.82%	40

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Baring Asset Management's ZBH Position: Q3 2015 in Review

Baring Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 49,467 shares — an estimated $5.25M sold.

Baring Asset Management first reported a position in ZBH in Q3 2014 and held it in 4 quarters. The position peaked at $14.4M in Q4 2014. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Baring Asset Management reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Baring Asset Management sold 49,467 Zimmer Biomet shares in Q3 2015, an estimated $5.25M.
Baring Asset Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 4 quarters.
Baring Asset Management's Zimmer Biomet position peaked at $14.4M in Q4 2014.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Baring Asset Management's 13F filing for Q3 2015, filed 20 Oct 2015.